Complete reconstruction of dasatinib unbinding pathway from c-Src kinase by supervised molecular dynamics simulation method; assessing efficiency and trustworthiness of the method

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Anderson, A. C. (2003). The process of structure-based drug design. Chemistry & Biology, 10(9), 787–797. https://doi.org/10.1016/j.chembiol.2003.09.002
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Bernetti, M., Masetti, M., Recanatini, M., Amaro, R. E., & Cavalli, A. (2019). An integrated Markov state model and path metadynamics approach to characterize drug binding processes. Journal of Chemical Theory and Computation, 15(10), 5689–5702. https://doi.org/10.1021/acs.jctc.9b00450
   PubMed Web of Science ®Google Scholar
• Blundell, T. L. (1996). Structure-based drug design. Nature, 384(6604 Suppl), 23–26. https://doi.org/10.1038/384023a0.
   PubMed Web of Science ®Google Scholar
• Bruno, A., Barresi, E., Simola, N., Da Pozzo, E., Costa, B., Novellino, E., Da Settimo, F., Martini, C., Taliani, S., & Cosconati, S. (2019). Unbinding of translocator protein 18 kDa (TSPO) ligands: From in vitro residence time to in vivo efficacy via in silico simulations. ACS Chemical Neuroscience, 10(8), 3805–3814. https://doi.org/10.1021/acschemneuro.9b00300
   PubMed Web of Science ®Google Scholar
• Buch, I., Giorgino, T., & De Fabritiis, G. (2011). Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations. Proceedings of the National Academy of Sciences of the United States of America, 108(25), 10184–10189. https://doi.org/10.1073/pnas.1103547108
   PubMed Web of Science ®Google Scholar
• Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. The Journal of Chemical Physics, 126(1), 014101. https://doi.org/10.1063/1.2408420
   PubMed Web of Science ®Google Scholar
• Capelli, R., Carloni, P., & Parrinello, M. (2019). Exhaustive search of ligand binding pathways via volume-based metadynamics. The Journal of Physical Chemistry Letters, 10(12), 3495–3499. https://doi.org/10.1021/acs.jpclett.9b01183
   PubMed Web of Science ®Google Scholar
• Capelli, R., Lyu, W., Bolnykh, V., Meloni, S., Olsen, J. M. H., Rothlisberger, U., Parrinello, M., & Carloni, P. (2020). Accuracy of molecular simulation-based predictions of Koff values: A metadynamics study. The Journal of Physical Chemistry Letters, 11(15), 6373–6381. https://doi.org/10.1021/acs.jpclett.0c00999
   PubMed Web of Science ®Google Scholar
• Casasnovas, R., Limongelli, V., Tiwary, P., Carloni, P., & Parrinello, M. (2017). Unbinding kinetics of a p38 MAP kinase type II inhibitor from metadynamics simulations. Journal of the American Chemical Society, 139(13), 4780–4788. https://doi.org/10.1021/jacs.6b12950
   PubMed Web of Science ®Google Scholar
• Dandekar, B. R., & Mondal, J. (2020). Capturing protein-ligand recognition pathways in coarse-grained simulation. The Journal of Physical Chemistry Letters, 11(13), 5302–5311. https://doi.org/10.1021/acs.jpclett.0c01683
   PubMed Web of Science ®Google Scholar
• D’Annessa, I., Raniolo, S., Limongelli, V., Di Marino, D., & Colombo, G. (2019). Ligand binding, unbinding, and allosteric effects: Deciphering small-molecule modulation of HSP90. Journal of Chemical Theory and Computation, 15(11), 6368–6381. https://doi.org/10.1021/acs.jctc.9b00319
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Deganutti, G., Moro, S., & Reynolds, C. A. (2020). A supervised molecular dynamics approach to unbiased ligand-protein unbinding. Journal of Chemical Information and Modeling, 60(3), 1804–1817. https://doi.org/10.1021/acs.jcim.9b01094
   PubMed Web of Science ®Google Scholar
• Deganutti, G., Welihinda, A., & Moro, S. (2017). Comparison of the human A2A adenosine receptor recognition by adenosine and inosine: New insight from supervised molecular dynamics simulations. ChemMedChem., 12(16), 1319–1326. https://doi.org/10.1002/cmdc.201700200
   PubMed Web of Science ®Google Scholar
• Dodda, L. S., Tirado-Rives, J., & Jorgensen, W. L. (2019). Unbinding dynamics of non-nucleoside inhibitors from HIV-1 reverse transcriptase. The Journal of Physical Chemistry B, 123(8), 1741–1748. https://doi.org/10.1021/acs.jpcb.8b10341
   PubMed Web of Science ®Google Scholar
• Dror, R. O., Pan, A. C., Arlow, D. H., Borhani, D. W., Maragakis, P., Shan, Y., Xu, H., & Shaw, D. E. (2011). Pathway and mechanism of drug binding to G-protein-coupled receptors. Proceedings of the National Academy of Sciences of the United States of America, 108(32), 13118–13123. https://doi.org/10.1073/pnas.1104614108
   PubMed Web of Science ®Google Scholar
• Fischer, A., & Smieško, M. (2019). Spontaneous ligand access events to membrane-bound cytochrome P450 2D6 sampled at atomic resolution. Scientific Reports, 9(1), 16411. https://doi.org/10.1038/s41598-019-52681-w
   PubMedGoogle Scholar
• Gane, P. J., & Dean, P. M. (2000). Recent advances in structure-based rational drug design. Current opinion in Structural Biology, 10(4), 401–404. https://doi.org/10.1016/s0959-440x(00)00105-6
   PubMed Web of Science ®Google Scholar
• Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., Davies, M., Dedman, N., Karlsson, A., Magariños, M. P., Overington, J. P., Papadatos, G., Smit, I., & Leach, A. R. (2017). The ChEMBL database in 2017. Nucleic Acids Research, 45(D1), D945–D954. https://doi.org/10.1093/nar/gkw1074
   PubMed Web of Science ®Google Scholar
• Getlik, M., Grütter, C., Simard, J. R., Klüter, S., Rabiller, M., Rode, H. B., Robubi, A., & Rauh, D. (2009). Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc. Journal of Medicinal Chemistry, 52(13), 3915–3926. https://doi.org/10.1021/jm9002928
   PubMed Web of Science ®Google Scholar
• Gohlke, H., Hergert, U., Meyer, T., Mulnaes, D., Grieshaber, M. K., Smits, S. H. J., & Schmitt, L. (2013). Binding region of alanopine dehydrogenase predicted by unbiased molecular dynamics simulations of ligand diffusion. Journal of Chemical Information and Modeling, 53(10), 2493–2498. https://doi.org/10.1021/ci400370y
   PubMed Web of Science ®Google Scholar
• Greer, J., Erickson, J. W., Baldwin, J. J., & Varney, M. D. (1994). Application of the three-dimensional structures of protein target molecules in structure-based drug design. Journal of Medicinal Chemistry, 37(8), 1035–1054. https://doi.org/10.1021/jm00034a001
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12 < 1463::AID-JCC4 > 3.0.CO;2-H
   Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Hunter, J. D. (2007). Matplotlib: A 2D graphics environment. Computing in Science & Engineering, 9(3), 90–95. https://doi.org/10.1109/MCSE.2007.55
   Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
   Web of Science ®Google Scholar
• Kalyaanamoorthy, S., & Chen, Y.-P P. (2011). Structure-based drug design to augment hit discovery. Drug Discovery Today, 16(17–18), 831–839. https://doi.org/10.1016/j.drudis.2011.07.006
   PubMed Web of Science ®Google Scholar
• Kaminski, G. A., Friesner, R. A., Tirado-Rives, J., & Jorgensen, W. L. (2001). Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. The Journal of Physical Chemistry B, 105(28), 6474–6487. https://doi.org/10.1021/jp003919d
   Web of Science ®Google Scholar
• Klebe, G. (2000). Recent developments in structure-based drug design. Journal of Molecular Medicine (Berlin, Germany), 78(5), 269–281. https://doi.org/10.1007/s001090000084
   PubMed Web of Science ®Google Scholar
• Kraus, D. (2014). Consolidated data analysis and presentation using an open-source add-in for the Microsoft Excel® spreadsheet software. Medical Writing, 23(1), 25–28. https://doi.org/10.1179/2047480613Z.000000000181
   Google Scholar
• Kumari, R., Kumar, R., Lynn, A., & Open Source Drug Discovery Consortium. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lotz, S. D., & Dickson, A. (2018). Unbiased molecular dynamics of 11 min timescale drug unbinding reveals transition state stabilizing interactions. Journal of the American Chemical Society, 140(2), 618–628. https://doi.org/10.1021/jacs.7b08572
   PubMed Web of Science ®Google Scholar
• Lüdemann, S. K., Carugo, O., & Wade, R. C. (1997). Substrate access to cytochrome P450cam: A comparison of a thermal motion pathway analysis with molecular dynamics simulation data. Journal of Molecular Modeling, 3(8), 369–374. https://doi.org/10.1007/s008940050053
   Web of Science ®Google Scholar
• Lüdemann, S. K., Lounnas, V., & Wade, R. C. (2000). How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms11Edited by J. Thornton. Journal of Molecular Biology, 303(5), 797–811. https://doi.org/10.1006/jmbi.2000.4154
   PubMed Web of Science ®Google Scholar
• Mandal, S., Moudgil, M. n., & Mandal, S. K. (2009). Rational drug design. European Journal of Pharmacology, 625(1–3), 90–100. https://doi.org/10.1016/j.ejphar.2009.06.065
   PubMed Web of Science ®Google Scholar
• Mollica, L., Decherchi, S., Zia, S. R., Gaspari, R., Cavalli, A., & Rocchia, W. (2015). Kinetics of protein-ligand unbinding via smoothed potential molecular dynamics simulations. Scientific Reports, 5, 11539. https://doi.org/10.1038/srep11539
   PubMed Web of Science ®Google Scholar
• Morando, M. A., Saladino, G., D'Amelio, N., Pucheta-Martinez, E., Lovera, S., Lelli, M., López-Méndez, B., Marenchino, M., Campos-Olivas, R., & Gervasio, F. L. (2016). Conformational selection and induced fit mechanisms in the binding of an anticancer drug to the c-Src kinase. Scientific Reports, 6(1), 24439. https://doi.org/10.1038/srep24439
   PubMedGoogle Scholar
• Niitsu, A., Re, S., Oshima, H., Kamiya, M., & Sugita, Y. (2019). De novo prediction of binders and nonbinders for T4 lysozyme by gREST simulations. Journal of Chemical Information and Modeling, 59(9), 3879–3888. https://doi.org/10.1021/acs.jcim.9b00416
   PubMed Web of Science ®Google Scholar
• Niu, Y., Li, S., Pan, D., Liu, H., & Yao, X. (2016). Computational study on the unbinding pathways of B-RAF inhibitors and its implication for the difference of residence time: Insight from random acceleration and steered molecular dynamics simulations. Physical Chemistry Chemical Physics : PCCP, 18(7), 5622–5629. https://doi.org/10.1039/C5CP06257H
   PubMed Web of Science ®Google Scholar
• Núñez, S., Venhorst, J., & Kruse, C. G. (2012). Target-drug interactions: First principles and their application to drug discovery. Drug Discovery Today, 17(1-2), 10–22. https://doi.org/10.1016/j.drudis.2011.06.013
   PubMed Web of Science ®Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/10.1063/1.328693
   Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Piana, S., & Laio, A. (2007). A bias-exchange approach to protein folding. The Journal of Physical Chemistry B, 111(17), 4553–4559. https://doi.org/10.1021/jp067873l
   PubMed Web of Science ®Google Scholar
• Pietrucci, F., Marinelli, F., Carloni, P., & Laio, A. (2009). Substrate binding mechanism of HIV-1 protease from explicit-solvent atomistic simulations. Journal of the American Chemical Society, 131(33), 11811–11818. https://doi.org/10.1021/ja903045y
   PubMed Web of Science ®Google Scholar
• Pramanik, D., Smith, Z., Kells, A., & Tiwary, P. (2019). Can one trust kinetic and thermodynamic observables from biased metadynamics simulations?: Detailed quantitative benchmarks on millimolar drug fragment dissociation. The Journal of Physical Chemistry B, 123(17), 3672–3678. https://doi.org/10.1021/acs.jpcb.9b01813
   PubMed Web of Science ®Google Scholar
• Pucheta-Martínez, E., Saladino, G., Morando, M. A., Martinez-Torrecuadrada, J., Lelli, M., Sutto, L., D'Amelio, N., & Gervasio, F. L. (2016). An allosteric cross-talk between the activation loop and the ATP binding site regulates the activation of Src kinase. Scientific Reports, 6, 24235. https://doi.org/10.1038/srep24235
   PubMed Web of Science ®Google Scholar
• Rydzewski, J., Jakubowski, R., Nowak, W., & Grubmüller, H. (2018). Kinetics of huperzine A dissociation from acetylcholinesterase via multiple unbinding pathways. Journal of Chemical Theory and Computation, 14(6), 2843–2851. https://doi.org/10.1021/acs.jctc.8b00173
   PubMed Web of Science ®Google Scholar
• Sabbadin, D., & Moro, S. (2014). Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale. Journal of Chemical Information and Modeling, 54(2), 372–376. https://doi.org/10.1021/ci400766b
   PubMed Web of Science ®Google Scholar
• Sabbadin, D., Salmaso, V., Sturlese, M., & Moro, S. (2018). Supervised molecular dynamics (SuMD) approaches in drug design. Methods in Molecular Biology (Clifton, NJ), 1824, 287–298. https://doi.org/10.1007/978-1-4939-8630-9_17
   PubMedGoogle Scholar
• Schuetz, D. A., Bernetti, M., Bertazzo, M., Musil, D., Eggenweiler, H.-M., Recanatini, M., Masetti, M., Ecker, G. F., & Cavalli, A. (2019). Predicting residence time and drug unbinding pathway through scaled molecular dynamics. Journal of Chemical Information and Modeling, 59(1), 535–549. https://doi.org/10.1021/acs.jcim.8b00614
   PubMed Web of Science ®Google Scholar
• Shan, Y., Kim, E. T., Eastwood, M. P., Dror, R. O., Seeliger, M. A., & Shaw, D. E. (2011). How does a drug molecule find its target binding site? Journal of the American Chemical Society, 133(24), 9181–9183. https://doi.org/10.1021/ja202726y
   PubMed Web of Science ®Google Scholar
• Shao, Q., & Zhu, W. (2019). Exploring the ligand binding/unbinding pathway by selectively enhanced sampling of ligand in a protein-ligand complex. The Journal of Physical Chemistry B, 123(38), 7974–7983. https://doi.org/10.1021/acs.jpcb.9b05226
   PubMed Web of Science ®Google Scholar
• Shukla, D., Meng, Y., Roux, B., & Pande, V. S. (2014). Activation pathway of Src kinase reveals intermediate states as targets for drug design. Nature Communications, 5, 3397. https://doi.org/10.1038/ncomms4397
   PubMed Web of Science ®Google Scholar
• Śledź, P., & Caflisch, A. (2018). Protein structure-based drug design: From docking to molecular dynamics. Current Opinion in Structural Biology, 48, 93–102. https://doi.org/10.1016/j.sbi.2017.10.010
   PubMed Web of Science ®Google Scholar
• Sohraby, F., & Aryapour, H. (2021). Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs. Seminars in Cancer Biology, 68, 249–257. https://doi.org/10.1016/j.semcancer.2020.04.007
   PubMed Web of Science ®Google Scholar
• Sohraby, F., Javaheri Moghadam, M., Aliyar, M., & Aryapour, H. (2020). A boosted unbiased molecular dynamics method for predicting ligands binding mechanisms: Probing the binding pathway of dasatinib to Src-kinase. Bioinformatics (Oxford, England), 36(18), 4714–4720. https://doi.org/10.1093/bioinformatics/btaa565
   PubMed Web of Science ®Google Scholar
• Sousa da Silva, A. W., & Vranken, W. F. (2012). ACPYPE - AnteChamber PYthon Parser interfacE. BMC Research Notes, 5, 367. https://doi.org/10.1186/1756-0500-5-367
   PubMedGoogle Scholar
• Souza, P. C. T., Thallmair, S., Conflitti, P., Ramírez-Palacios, C., Alessandri, R., Raniolo, S., Limongelli, V., & Marrink, S. J. (2020). Protein-ligand binding with the coarse-grained Martini model. Nature Communications, 11(1), 3714. https://doi.org/10.1038/s41467-020-17437-5
   PubMed Web of Science ®Google Scholar
• Tang, Z., & Chang, C-e A. (2018). Binding thermodynamics and kinetics calculations using chemical host and guest: A comprehensive picture of molecular recognition. Journal of Chemical Theory and Computation, 14(1), 303–318. https://doi.org/10.1021/acs.jctc.7b00899
   PubMed Web of Science ®Google Scholar
• Tiwary, P., Mondal, J., & Berne, B. J. (2017). How and when does an anticancer drug leave its binding site? Science Advances, 3(5), e1700014. https://doi.org/10.1126/sciadv.1700014
   PubMed Web of Science ®Google Scholar
• Tiwary, P., Limongelli, V., Salvalaglio, M., & Parrinello, M. (2015). Kinetics of protein-ligand unbinding: Predicting pathways, rates, and rate-limiting steps. Proceedings of the National Academy of Sciences of the United States of America, 112(5), E386–391. https://doi.org/10.1073/pnas.1424461112
   PubMed Web of Science ®Google Scholar
• Vandyke, K., Fitter, S., & Zannettino, A. C. W. (2011). The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation. Blood Cancer Journal, 1(2), e2. https://doi.org/10.1038/bcj.2011.1
   PubMedGoogle Scholar
• Verlinde, C. L. M. J., & Hol, W. G. J. (1994). Structure-based drug design: Progress, results and challenges. Structure (London, England: 1993), 2(7), 577–587. https://doi.org/10.1016/s0969-2126(00)00060-5
   PubMed Web of Science ®Google Scholar
• Zeller, F., Luitz, M. P., Bomblies, R., & Zacharias, M. (2017). Multiscale simulation of receptor-drug association kinetics: Application to neuraminidase inhibitors. Journal of Chemical Theory and Computation, 13(10), 5097–5105. https://doi.org/10.1021/acs.jctc.7b00631
   PubMed Web of Science ®Google Scholar